Home / Emtricitabine, Tenofovir Disoproxil and Efavirenz / Canada
CA ATC J05AR06 · updated 2 Nov 2026
Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage in Canada
Is there an Emtricitabine, Tenofovir Disoproxil and Efavirenz shortage in Canada?
Yes. As of 2 Nov 2026, 3 Emtricitabine, Tenofovir Disoproxil and Efavirenz products are reported short in Canada, the first since 7 Oct 2024. The company estimate for the return is 1 Jan 2028. Main reason: manufacturing problem.
Also short in Italy, Belgium, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (30BT) | MYLAN PHARMACEUTICALS ULC | 7 Oct 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR (30) | TEVA CANADA LIMITED | 20 Jan 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (Bottle / Bouteille 30) | JAMP PHARMA CORPORATION | 12 Mar 2026 | 1 Jan 2028 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.